tetracyclines
Recent Rosacea Blog Posts

In 2017, the FDA approved the extended release formulation of minocycline, known as Minolira, for the treatment of severe acne vulgaris. The modified release formulation of doxycycline known as Oracea, was approved for the treatment of rosacea in 2006. As minocycline and doxycycline are related tetracyclines, Minolira may offer rosacea sufferers another rosacea treatment option, […]

A pre-proof version of an article to appear in the Journal of the American Academy of Dermatology details a small double blind study that found that oral hydroxychloroquine 200mg twice a day offered similar benefits to rosacea sufferers compared to doxycycline 100mg a day. Hydroxycholorquine (HCQ) is marketed under the name Plaquenil and is best […]

In a crowded rosacea topical market, Hovione is trialing a new topical antibiotic formulation – 1% vs. 3% minocycline gel. HY01 is said to be based on a “proprietary formulation of crystalline minocycline base and oil-based excipients.” In the topical anti-papule and pustule market, this new formulation of Minocycline is up against the industry heavyweights […]

I don’t know if rosacea sufferers really need another tetracycline variant, but Allergan has published some promising Phase III trial data for Sarecycline as a treatment for the lesions of moderate to severe acne. Whilst no longer being directly promoted as a treatment for rosacea (and indeed it is not clear if Allergan will be […]
The New York Times is reporting on the health status of the President, based on an interview with his doctor – Harold N. Bornstein. The interview includes mention that Trump is taking a long acting tetracycline to control his rosacea. It isn’t clear which formulation of tetracycline this would refer to. I’m sure the reporting is […]